VANDAZOLE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Vandazole, and what generic alternatives are available?
Vandazole is a drug marketed by Teva Pharms and is included in one NDA. There is one patent protecting this drug.
The generic ingredient in VANDAZOLE is metronidazole. There are eighteen drug master file entries for this compound. Seventy-one suppliers are listed for this compound. Additional details are available on the metronidazole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Vandazole
A generic version of VANDAZOLE was approved as metronidazole by TEVA PHARMS USA on November 6th, 1984.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for VANDAZOLE?
- What are the global sales for VANDAZOLE?
- What is Average Wholesale Price for VANDAZOLE?
Summary for VANDAZOLE
| US Patents: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 172 |
| Clinical Trials: | 1 |
| Patent Applications: | 3,296 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for VANDAZOLE |
| What excipients (inactive ingredients) are in VANDAZOLE? | VANDAZOLE excipients list |
| DailyMed Link: | VANDAZOLE at DailyMed |
Recent Clinical Trials for VANDAZOLE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| New York Medical College | Phase 4 |
Pharmacology for VANDAZOLE
| Drug Class | Nitroimidazole Antimicrobial |
US Patents and Regulatory Information for VANDAZOLE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Pharms | VANDAZOLE | metronidazole | GEL;VAGINAL | 021806-001 | May 20, 2005 | BX | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
